Ah..I've never visited the flxn board..I own no shares there...I can't answer what he posts there or why.....I just know that this equity, to date, has been nothing but a disappointment... ampion has failed it's last three trials...close doesn't count, saline effect doesn't count, frozen drugs don't count... 95 cents a share counts
Moon...how many successful phase III trials has macaluso led???. I don't care about your disdain about Bill...you can make it personal and prattle on about Bill, but fact is another trial regarding ampion failed, and optima appears worthless...if you desire to be happy about this so be it, but shares are at 95 cents for a reason and if another trial is in the offing expect large dilution..if you believe the FDA will approve as is I'd be absolutely amazed
His bs??????? What has bill been incorrect about in the past two years??? For your edification, ampe has failed multiple trials, frozen samples, super duper saline, and now not achieving its endpoint's..Zippo on optima..how many times do you have to be hit in the head before yelling "stop"?
Are you on crack?..this is not a capacity issue, and your implication that this occurred because they can't keep up with demand is preposterous... further, this didn't just come up and it is irresponsible of management to the nth degree that they didn't inform the market earlier so as to ensure that patients taking the drug could continue to do so without interruption.... finally, they say the drug will be available in 2-5 months (fourth quarter)...that's a pretty big window...shame on management for not putting Patients first